nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—ALB—liver cancer	0.814	1	CbGaD
Magnesium salicylate—Hypocalcaemia—Sorafenib—liver cancer	0.00249	0.0392	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Sorafenib—liver cancer	0.00218	0.0342	CcSEcCtD
Magnesium salicylate—Olsalazine—PPARG—liver cancer	0.00203	0.635	CrCbGaD
Magnesium salicylate—Abdominal pain upper—Sorafenib—liver cancer	0.00151	0.0238	CcSEcCtD
Magnesium salicylate—Hypothermia—Epirubicin—liver cancer	0.0015	0.0237	CcSEcCtD
Magnesium salicylate—Body temperature decreased—Epirubicin—liver cancer	0.0015	0.0237	CcSEcCtD
Magnesium salicylate—Gastric ulcer—Epirubicin—liver cancer	0.00145	0.0228	CcSEcCtD
Magnesium salicylate—Body temperature decreased—Doxorubicin—liver cancer	0.00139	0.0219	CcSEcCtD
Magnesium salicylate—Hypothermia—Doxorubicin—liver cancer	0.00139	0.0219	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Sorafenib—liver cancer	0.00137	0.0216	CcSEcCtD
Magnesium salicylate—Gastric ulcer—Doxorubicin—liver cancer	0.00134	0.0211	CcSEcCtD
Magnesium salicylate—Burning sensation—Epirubicin—liver cancer	0.00121	0.0191	CcSEcCtD
Magnesium salicylate—Epistaxis—Sorafenib—liver cancer	0.0012	0.0189	CcSEcCtD
Magnesium salicylate—Burning sensation—Doxorubicin—liver cancer	0.00112	0.0177	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Sorafenib—liver cancer	0.00108	0.017	CcSEcCtD
Magnesium salicylate—Tinnitus—Sorafenib—liver cancer	0.00107	0.0168	CcSEcCtD
Magnesium salicylate—Flushing—Sorafenib—liver cancer	0.00106	0.0167	CcSEcCtD
Magnesium salicylate—Stinging—Epirubicin—liver cancer	0.00104	0.0164	CcSEcCtD
Magnesium salicylate—Erythema—Sorafenib—liver cancer	0.000997	0.0157	CcSEcCtD
Magnesium salicylate—Dysgeusia—Sorafenib—liver cancer	0.000976	0.0154	CcSEcCtD
Magnesium salicylate—Stinging—Doxorubicin—liver cancer	0.000963	0.0151	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Epirubicin—liver cancer	0.000921	0.0145	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Doxorubicin—liver cancer	0.000852	0.0134	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Epirubicin—liver cancer	0.000805	0.0127	CcSEcCtD
Magnesium salicylate—Shock—Sorafenib—liver cancer	0.000801	0.0126	CcSEcCtD
Magnesium salicylate—Anorexia—Sorafenib—liver cancer	0.000776	0.0122	CcSEcCtD
Magnesium salicylate—Oesophagitis—Epirubicin—liver cancer	0.00077	0.0121	CcSEcCtD
Magnesium salicylate—Ecchymosis—Epirubicin—liver cancer	0.000762	0.012	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Doxorubicin—liver cancer	0.000745	0.0117	CcSEcCtD
Magnesium salicylate—Dyspepsia—Sorafenib—liver cancer	0.000716	0.0113	CcSEcCtD
Magnesium salicylate—Oesophagitis—Doxorubicin—liver cancer	0.000713	0.0112	CcSEcCtD
Magnesium salicylate—Decreased appetite—Sorafenib—liver cancer	0.000707	0.0111	CcSEcCtD
Magnesium salicylate—Ecchymosis—Doxorubicin—liver cancer	0.000705	0.0111	CcSEcCtD
Magnesium salicylate—Constipation—Sorafenib—liver cancer	0.000696	0.0109	CcSEcCtD
Magnesium salicylate—Pain—Sorafenib—liver cancer	0.000696	0.0109	CcSEcCtD
Magnesium salicylate—Urticaria—Sorafenib—liver cancer	0.000646	0.0102	CcSEcCtD
Magnesium salicylate—Lethargy—Epirubicin—liver cancer	0.000624	0.00982	CcSEcCtD
Magnesium salicylate—Lethargy—Doxorubicin—liver cancer	0.000578	0.00909	CcSEcCtD
Magnesium salicylate—Pruritus—Sorafenib—liver cancer	0.000576	0.00906	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Epirubicin—liver cancer	0.000559	0.00879	CcSEcCtD
Magnesium salicylate—Diarrhoea—Sorafenib—liver cancer	0.000557	0.00876	CcSEcCtD
Magnesium salicylate—Dizziness—Sorafenib—liver cancer	0.000538	0.00846	CcSEcCtD
Magnesium salicylate—Asthma—Epirubicin—liver cancer	0.000529	0.00832	CcSEcCtD
Magnesium salicylate—Vomiting—Sorafenib—liver cancer	0.000517	0.00814	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Doxorubicin—liver cancer	0.000517	0.00813	CcSEcCtD
Magnesium salicylate—Rash—Sorafenib—liver cancer	0.000513	0.00807	CcSEcCtD
Magnesium salicylate—Dermatitis—Sorafenib—liver cancer	0.000513	0.00806	CcSEcCtD
Magnesium salicylate—Headache—Sorafenib—liver cancer	0.00051	0.00802	CcSEcCtD
Magnesium salicylate—Asthma—Doxorubicin—liver cancer	0.000489	0.0077	CcSEcCtD
Magnesium salicylate—Nausea—Sorafenib—liver cancer	0.000483	0.0076	CcSEcCtD
Magnesium salicylate—Weight increased—Epirubicin—liver cancer	0.000481	0.00757	CcSEcCtD
Magnesium salicylate—Drowsiness—Epirubicin—liver cancer	0.000472	0.00742	CcSEcCtD
Magnesium salicylate—Sweating—Epirubicin—liver cancer	0.000452	0.00711	CcSEcCtD
Magnesium salicylate—Oxcarbazepine—ALB—liver cancer	0.000449	0.141	CrCbGaD
Magnesium salicylate—Weight increased—Doxorubicin—liver cancer	0.000445	0.007	CcSEcCtD
Magnesium salicylate—Epistaxis—Epirubicin—liver cancer	0.000445	0.007	CcSEcCtD
Magnesium salicylate—Drowsiness—Doxorubicin—liver cancer	0.000436	0.00686	CcSEcCtD
Magnesium salicylate—Hepatitis—Epirubicin—liver cancer	0.000423	0.00666	CcSEcCtD
Magnesium salicylate—Sweating—Doxorubicin—liver cancer	0.000418	0.00658	CcSEcCtD
Magnesium salicylate—Epistaxis—Doxorubicin—liver cancer	0.000412	0.00647	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Epirubicin—liver cancer	0.0004	0.0063	CcSEcCtD
Magnesium salicylate—Salicylic acid—ALB—liver cancer	0.000398	0.125	CrCbGaD
Magnesium salicylate—Tinnitus—Epirubicin—liver cancer	0.000395	0.00621	CcSEcCtD
Magnesium salicylate—Flushing—Epirubicin—liver cancer	0.000393	0.00618	CcSEcCtD
Magnesium salicylate—Hepatitis—Doxorubicin—liver cancer	0.000392	0.00616	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Doxorubicin—liver cancer	0.00037	0.00582	CcSEcCtD
Magnesium salicylate—Erythema—Epirubicin—liver cancer	0.000368	0.0058	CcSEcCtD
Magnesium salicylate—Tinnitus—Doxorubicin—liver cancer	0.000365	0.00574	CcSEcCtD
Magnesium salicylate—Flushing—Doxorubicin—liver cancer	0.000363	0.00572	CcSEcCtD
Magnesium salicylate—Dysgeusia—Epirubicin—liver cancer	0.000361	0.00568	CcSEcCtD
Magnesium salicylate—Erythema—Doxorubicin—liver cancer	0.000341	0.00536	CcSEcCtD
Magnesium salicylate—Dysgeusia—Doxorubicin—liver cancer	0.000334	0.00525	CcSEcCtD
Magnesium salicylate—Ketoprofen—ALB—liver cancer	0.000316	0.0991	CrCbGaD
Magnesium salicylate—Confusional state—Epirubicin—liver cancer	0.000303	0.00477	CcSEcCtD
Magnesium salicylate—Oedema—Epirubicin—liver cancer	0.000301	0.00473	CcSEcCtD
Magnesium salicylate—Shock—Epirubicin—liver cancer	0.000296	0.00465	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Epirubicin—liver cancer	0.000291	0.00457	CcSEcCtD
Magnesium salicylate—Anorexia—Epirubicin—liver cancer	0.000287	0.00451	CcSEcCtD
Magnesium salicylate—Hypotension—Epirubicin—liver cancer	0.000281	0.00442	CcSEcCtD
Magnesium salicylate—Confusional state—Doxorubicin—liver cancer	0.000281	0.00441	CcSEcCtD
Magnesium salicylate—Oedema—Doxorubicin—liver cancer	0.000278	0.00438	CcSEcCtD
Magnesium salicylate—Shock—Doxorubicin—liver cancer	0.000274	0.00431	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Doxorubicin—liver cancer	0.000269	0.00423	CcSEcCtD
Magnesium salicylate—Somnolence—Epirubicin—liver cancer	0.000267	0.00421	CcSEcCtD
Magnesium salicylate—Anorexia—Doxorubicin—liver cancer	0.000265	0.00417	CcSEcCtD
Magnesium salicylate—Dyspepsia—Epirubicin—liver cancer	0.000265	0.00416	CcSEcCtD
Magnesium salicylate—Decreased appetite—Epirubicin—liver cancer	0.000261	0.00411	CcSEcCtD
Magnesium salicylate—Hypotension—Doxorubicin—liver cancer	0.00026	0.00409	CcSEcCtD
Magnesium salicylate—Constipation—Epirubicin—liver cancer	0.000257	0.00404	CcSEcCtD
Magnesium salicylate—Pain—Epirubicin—liver cancer	0.000257	0.00404	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Epirubicin—liver cancer	0.000248	0.0039	CcSEcCtD
Magnesium salicylate—Somnolence—Doxorubicin—liver cancer	0.000247	0.00389	CcSEcCtD
Magnesium salicylate—Dyspepsia—Doxorubicin—liver cancer	0.000245	0.00385	CcSEcCtD
Magnesium salicylate—Decreased appetite—Doxorubicin—liver cancer	0.000242	0.0038	CcSEcCtD
Magnesium salicylate—Urticaria—Epirubicin—liver cancer	0.000239	0.00376	CcSEcCtD
Magnesium salicylate—Constipation—Doxorubicin—liver cancer	0.000238	0.00374	CcSEcCtD
Magnesium salicylate—Pain—Doxorubicin—liver cancer	0.000238	0.00374	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Doxorubicin—liver cancer	0.000229	0.00361	CcSEcCtD
Magnesium salicylate—Urticaria—Doxorubicin—liver cancer	0.000221	0.00348	CcSEcCtD
Magnesium salicylate—Pruritus—Epirubicin—liver cancer	0.000213	0.00335	CcSEcCtD
Magnesium salicylate—Diarrhoea—Epirubicin—liver cancer	0.000206	0.00324	CcSEcCtD
Magnesium salicylate—Dizziness—Epirubicin—liver cancer	0.000199	0.00313	CcSEcCtD
Magnesium salicylate—Pruritus—Doxorubicin—liver cancer	0.000197	0.0031	CcSEcCtD
Magnesium salicylate—Vomiting—Epirubicin—liver cancer	0.000191	0.00301	CcSEcCtD
Magnesium salicylate—Diarrhoea—Doxorubicin—liver cancer	0.00019	0.00299	CcSEcCtD
Magnesium salicylate—Rash—Epirubicin—liver cancer	0.00019	0.00298	CcSEcCtD
Magnesium salicylate—Dermatitis—Epirubicin—liver cancer	0.000189	0.00298	CcSEcCtD
Magnesium salicylate—Headache—Epirubicin—liver cancer	0.000188	0.00296	CcSEcCtD
Magnesium salicylate—Dizziness—Doxorubicin—liver cancer	0.000184	0.00289	CcSEcCtD
Magnesium salicylate—Nausea—Epirubicin—liver cancer	0.000179	0.00281	CcSEcCtD
Magnesium salicylate—Vomiting—Doxorubicin—liver cancer	0.000177	0.00278	CcSEcCtD
Magnesium salicylate—Rash—Doxorubicin—liver cancer	0.000175	0.00276	CcSEcCtD
Magnesium salicylate—Dermatitis—Doxorubicin—liver cancer	0.000175	0.00276	CcSEcCtD
Magnesium salicylate—Headache—Doxorubicin—liver cancer	0.000174	0.00274	CcSEcCtD
Magnesium salicylate—Nausea—Doxorubicin—liver cancer	0.000165	0.0026	CcSEcCtD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000157	0.00131	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000152	0.00127	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000152	0.00127	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000151	0.00126	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PRKCE—liver cancer	0.000149	0.00124	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000148	0.00124	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—MYC—liver cancer	0.000146	0.00122	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000145	0.00121	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CDKN1B—liver cancer	0.000145	0.00121	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000144	0.0012	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000143	0.00119	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—UGDH—liver cancer	0.000143	0.00119	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CASP3—liver cancer	0.000142	0.00119	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL2—liver cancer	0.000142	0.00119	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IGF2—liver cancer	0.000141	0.00118	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CCND1—liver cancer	0.000139	0.00116	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000137	0.00115	CbGpPWpGaD
Magnesium salicylate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.000137	0.00115	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—KRAS—liver cancer	0.000135	0.00113	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MMP9—liver cancer	0.000134	0.00112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—EPT1—liver cancer	0.000134	0.00112	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—VEGFA—liver cancer	0.000133	0.00111	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TNF—liver cancer	0.000133	0.00111	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—HGF—liver cancer	0.000133	0.00111	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—IL6—liver cancer	0.000133	0.00111	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—IL6—liver cancer	0.000132	0.0011	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—CSF2—liver cancer	0.000132	0.0011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—TNF—liver cancer	0.000131	0.00109	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TAT—liver cancer	0.000127	0.00106	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	0.000127	0.00106	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000125	0.00104	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—TGFB1—liver cancer	0.000122	0.00102	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000118	0.000984	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TP53—liver cancer	0.000117	0.000981	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	0.000117	0.000973	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SERPINA1—liver cancer	0.000116	0.000973	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000116	0.000966	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—UGDH—liver cancer	0.000115	0.000964	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—HRAS—liver cancer	0.000115	0.000956	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MYC—liver cancer	0.000111	0.000928	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TGFB1—liver cancer	0.000111	0.000926	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GLUL—liver cancer	0.000109	0.000909	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CPT1B—liver cancer	0.000109	0.000909	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—EPT1—liver cancer	0.000108	0.000906	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000108	0.0009	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL6—liver cancer	0.000108	0.000898	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—MAPK14—liver cancer	0.000107	0.00089	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TNF—liver cancer	0.000106	0.000884	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IL6—liver cancer	0.000106	0.000882	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NR1H4—liver cancer	0.000105	0.000876	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TNF—liver cancer	0.000103	0.000864	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—F2—liver cancer	0.000103	0.000863	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTA3—liver cancer	0.000103	0.000862	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—LTF—liver cancer	0.000103	0.000862	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TAT—liver cancer	0.000103	0.000859	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000101	0.000845	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	9.89e-05	0.000826	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	9.88e-05	0.000825	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	9.68e-05	0.000808	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTA4—liver cancer	9.44e-05	0.000788	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	9.42e-05	0.000787	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	9.4e-05	0.000785	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	9.36e-05	0.000781	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	9.33e-05	0.000779	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	9.22e-05	0.00077	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTA2—liver cancer	9.2e-05	0.000768	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—liver cancer	9.12e-05	0.000762	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	9.11e-05	0.000761	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	8.9e-05	0.000743	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTA1—liver cancer	8.87e-05	0.000741	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NAT2—liver cancer	8.77e-05	0.000733	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	8.69e-05	0.000726	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNA1—liver cancer	8.67e-05	0.000724	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CPT1B—liver cancer	8.64e-05	0.000722	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GLUL—liver cancer	8.64e-05	0.000722	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	8.6e-05	0.000718	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IL6—liver cancer	8.54e-05	0.000713	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.44e-05	0.000704	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALDOB—liver cancer	8.41e-05	0.000702	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL6—liver cancer	8.35e-05	0.000697	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NR1H4—liver cancer	8.33e-05	0.000696	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	8.21e-05	0.000686	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTA3—liver cancer	8.19e-05	0.000684	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CRABP1—liver cancer	8.02e-05	0.00067	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ALDOB—liver cancer	7.97e-05	0.000666	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	7.76e-05	0.000648	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PRKCE—liver cancer	7.67e-05	0.000641	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	7.58e-05	0.000633	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	7.57e-05	0.000632	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	7.56e-05	0.000631	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	7.54e-05	0.00063	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTA4—liver cancer	7.49e-05	0.000626	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	7.34e-05	0.000613	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	7.32e-05	0.000611	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTA2—liver cancer	7.3e-05	0.00061	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ABL1—liver cancer	7.3e-05	0.00061	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IGF2—liver cancer	7.27e-05	0.000607	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.22e-05	0.000603	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTA1—liver cancer	7.04e-05	0.000588	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	7.04e-05	0.000588	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—HPGDS—liver cancer	7.01e-05	0.000586	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CPT1B—liver cancer	6.99e-05	0.000584	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GLUL—liver cancer	6.99e-05	0.000584	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	6.98e-05	0.000583	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.97e-05	0.000582	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NAT2—liver cancer	6.96e-05	0.000582	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	6.96e-05	0.000581	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HGF—liver cancer	6.86e-05	0.000573	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CSF2—liver cancer	6.79e-05	0.000567	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NR1H4—liver cancer	6.74e-05	0.000563	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.7e-05	0.000559	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALDOB—liver cancer	6.68e-05	0.000558	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTA3—liver cancer	6.63e-05	0.000553	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	6.42e-05	0.000536	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	6.38e-05	0.000533	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CRABP1—liver cancer	6.37e-05	0.000532	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.35e-05	0.00053	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ADAM17—liver cancer	6.3e-05	0.000526	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.27e-05	0.000524	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PSMD10—liver cancer	6.25e-05	0.000522	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PSMA4—liver cancer	6.25e-05	0.000522	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	6.21e-05	0.000518	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GOT2—liver cancer	6.08e-05	0.000508	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTA4—liver cancer	6.06e-05	0.000506	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PSMA4—liver cancer	5.93e-05	0.000495	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PSMD10—liver cancer	5.93e-05	0.000495	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.92e-05	0.000495	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	5.91e-05	0.000494	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTA2—liver cancer	5.91e-05	0.000493	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GOT2—liver cancer	5.76e-05	0.000481	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.74e-05	0.000479	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP2E1—liver cancer	5.72e-05	0.000477	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTA1—liver cancer	5.7e-05	0.000476	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NAT2—liver cancer	5.63e-05	0.000471	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—HPGDS—liver cancer	5.57e-05	0.000465	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.54e-05	0.000462	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.54e-05	0.000462	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MAPK14—liver cancer	5.5e-05	0.000459	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	5.43e-05	0.000453	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.42e-05	0.000452	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALDOB—liver cancer	5.4e-05	0.000451	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYCS—liver cancer	5.35e-05	0.000447	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—F2—liver cancer	5.33e-05	0.000445	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GGT1—liver cancer	5.25e-05	0.000438	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GOT1—liver cancer	5.25e-05	0.000438	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	5.24e-05	0.000438	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CRABP1—liver cancer	5.15e-05	0.00043	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	5.15e-05	0.00043	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CG—liver cancer	5.1e-05	0.000426	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.04e-05	0.000421	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.98e-05	0.000416	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GOT1—liver cancer	4.98e-05	0.000416	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PSMD10—liver cancer	4.96e-05	0.000414	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PSMA4—liver cancer	4.96e-05	0.000414	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GOT2—liver cancer	4.83e-05	0.000403	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTP1—liver cancer	4.72e-05	0.000394	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—HMOX1—liver cancer	4.65e-05	0.000388	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.64e-05	0.000387	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	4.62e-05	0.000386	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PRKCE—liver cancer	4.59e-05	0.000383	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP2E1—liver cancer	4.54e-05	0.000379	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HPGDS—liver cancer	4.5e-05	0.000376	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CD—liver cancer	4.48e-05	0.000374	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.48e-05	0.000374	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SERPINE1—liver cancer	4.43e-05	0.00037	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.39e-05	0.000367	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTM1—liver cancer	4.33e-05	0.000362	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYCS—liver cancer	4.25e-05	0.000355	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GOT1—liver cancer	4.17e-05	0.000348	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GGT1—liver cancer	4.17e-05	0.000348	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP1A1—liver cancer	4.11e-05	0.000343	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.08e-05	0.000341	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PSMA4—liver cancer	4.01e-05	0.000335	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PSMD10—liver cancer	4.01e-05	0.000335	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—H2AFX—liver cancer	4e-05	0.000334	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—RAF1—liver cancer	4e-05	0.000334	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GOT2—liver cancer	3.91e-05	0.000326	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CB—liver cancer	3.91e-05	0.000326	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—MTHFR—liver cancer	3.83e-05	0.00032	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	3.77e-05	0.000315	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PPARA—liver cancer	3.76e-05	0.000314	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTP1—liver cancer	3.74e-05	0.000313	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—HMOX1—liver cancer	3.69e-05	0.000308	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2E1—liver cancer	3.67e-05	0.000307	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTHFR—liver cancer	3.63e-05	0.000303	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TERT—liver cancer	3.62e-05	0.000302	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IL2—liver cancer	3.59e-05	0.0003	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.56e-05	0.000297	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	3.46e-05	0.000289	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTM1—liver cancer	3.44e-05	0.000287	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYCS—liver cancer	3.44e-05	0.000287	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.37e-05	0.000282	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GGT1—liver cancer	3.37e-05	0.000282	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GOT1—liver cancer	3.37e-05	0.000282	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP1A1—liver cancer	3.26e-05	0.000272	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CG—liver cancer	3.22e-05	0.000269	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PPARG—liver cancer	3.11e-05	0.000259	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APC—liver cancer	3.05e-05	0.000255	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—liver cancer	3.05e-05	0.000255	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MTHFR—liver cancer	3.04e-05	0.000254	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTP1—liver cancer	3.03e-05	0.000253	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HMOX1—liver cancer	2.99e-05	0.000249	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PPARA—liver cancer	2.98e-05	0.000249	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BRAF—liver cancer	2.87e-05	0.000239	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CD—liver cancer	2.83e-05	0.000236	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TGFB1—liver cancer	2.8e-05	0.000234	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALB—liver cancer	2.79e-05	0.000233	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTM1—liver cancer	2.78e-05	0.000232	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CD—liver cancer	2.68e-05	0.000224	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.68e-05	0.000224	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SERPINE1—liver cancer	2.65e-05	0.000221	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP1A1—liver cancer	2.64e-05	0.00022	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KRAS—liver cancer	2.59e-05	0.000216	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CG—liver cancer	2.55e-05	0.000213	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CB—liver cancer	2.47e-05	0.000206	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PPARG—liver cancer	2.47e-05	0.000206	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MTHFR—liver cancer	2.46e-05	0.000205	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PPARA—liver cancer	2.41e-05	0.000202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RAF1—liver cancer	2.39e-05	0.0002	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CA—liver cancer	2.38e-05	0.000199	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTOR—liver cancer	2.34e-05	0.000195	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CB—liver cancer	2.34e-05	0.000195	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—liver cancer	2.3e-05	0.000192	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CD—liver cancer	2.25e-05	0.000188	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALB—liver cancer	2.22e-05	0.000185	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HRAS—liver cancer	2.2e-05	0.000184	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1B—liver cancer	2.19e-05	0.000183	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.17e-05	0.000181	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CTNNB1—liver cancer	2.07e-05	0.000173	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CG—liver cancer	2.07e-05	0.000173	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1A—liver cancer	2.02e-05	0.000169	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PPARG—liver cancer	1.99e-05	0.000167	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CB—liver cancer	1.96e-05	0.000163	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT1—liver cancer	1.94e-05	0.000162	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CD—liver cancer	1.82e-05	0.000152	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT3—liver cancer	1.81e-05	0.000151	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—liver cancer	1.68e-05	0.00014	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFB1—liver cancer	1.67e-05	0.00014	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CB—liver cancer	1.58e-05	0.000132	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KRAS—liver cancer	1.55e-05	0.000129	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CA—liver cancer	1.5e-05	0.000126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CA—liver cancer	1.42e-05	0.000119	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HRAS—liver cancer	1.32e-05	0.00011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6—liver cancer	1.26e-05	0.000105	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKT1—liver cancer	1.23e-05	0.000103	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CA—liver cancer	1.19e-05	9.96e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT1—liver cancer	1.16e-05	9.72e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKT1—liver cancer	9.75e-06	8.14e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CA—liver cancer	9.65e-06	8.06e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKT1—liver cancer	7.89e-06	6.59e-05	CbGpPWpGaD
